Drug Type Small molecule drug |
Synonyms- |
Action partial agonists |
Mechanism 5-HT1A receptor partial agonists(Serotonin 1a (5-HT1a) receptor partial agonists), 5-HT2A receptor partial agonists(Serotonin 2a (5-HT2a) receptor partial agonists), D2 receptor partial agonists(Dopamine D2 receptor partial agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H26Cl3N3O3 |
InChIKeyGMTQOJSRMVAFIF-UHFFFAOYSA-N |
CAS Registry1708960-04-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Preclinical | China | 02 May 2018 |